These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 9600309

  • 1. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A, Nielsen HV, Bryder K, Nielsen C, Machuca R, Bruun L, Hansen J, Buus S.
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [Abstract] [Full Text] [Related]

  • 2. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H.
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [Abstract] [Full Text] [Related]

  • 3. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 4. Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg.
    Bryder K, Sbai H, Nielsen HV, Corbet S, Nielsen C, Whalen RG, Fomsgaard A.
    DNA Cell Biol; 1999 Mar 10; 18(3):219-25. PubMed ID: 10098603
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M, Holmgren J, Schödel F, Lebens M.
    Gene; 1995 Nov 20; 165(2):163-71. PubMed ID: 8522171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL, Schad VC, Goodwin WH, Brauer AB, Bollinger BK, Chin RD, Kuo MC.
    J Immunol; 1992 Jun 15; 148(12):3970-7. PubMed ID: 1376346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination.
    Riedl P, El-Kholy S, Reimann J, Schirmbeck R.
    J Immunol; 2002 Aug 01; 169(3):1251-60. PubMed ID: 12133946
    [Abstract] [Full Text] [Related]

  • 12. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE, Rodríguez D, Rodríguez JR, Abaitua F, Duarte C, Esteban M.
    Vaccine; 2001 Dec 12; 20(5-6):961-71. PubMed ID: 11738764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen.
    Schirmbeck R, Zheng X, Roggendorf M, Geissler M, Chisari FV, Reimann J, Lu M.
    J Immunol; 2001 Jan 15; 166(2):1405-13. PubMed ID: 11145726
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X, Schirmbeck R, Hilken G, Waters JA, Yang D, Reimann J, Roggendorf M, Lu M.
    Virology; 2002 Mar 15; 294(2):342-53. PubMed ID: 12009876
    [Abstract] [Full Text] [Related]

  • 18. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W, Ren L, Jin N.
    J Virol Methods; 2007 Dec 15; 146(1-2):266-73. PubMed ID: 17868910
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP, Doan T, Herd KA, Netter HJ, Tindle RW.
    J Virol; 2006 Apr 15; 80(8):3975-84. PubMed ID: 16571814
    [Abstract] [Full Text] [Related]

  • 20. Single peptide and anti-idiotype based immunizations can broaden the antibody response against the variable V3 domain of HIV-1 in mice.
    Boudet F, Keller H, Kieny MP, Thèze J.
    Mol Immunol; 1995 May 15; 32(7):449-57. PubMed ID: 7783749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.